R-Tech Ueno: Protocol Amendment of a Phase I Clinical Study of RK-023 for the Treatment of Hypotrichosis of the Eyelashes

Published: Jul 25, 2011

TOKYO--(BUSINESS WIRE)--R-Tech Ueno (JASDAQ:4573) is pleased to announce protocol amendment of a Phase I Clinical Study of RK-023, a new compound being developed for the treatment of hypotrichosis of the eyelashes (Note). The details are given below.

Back to news